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Background. Eighteen months is usually considered the cutoff time within which 
recovery of the mimic muscle remains possible using facial nerve cooptation. Few 
reports on the use of cooptation after this interval have appeared. Purpose of this study 
is to investigate the feasibility of this procedure also after 22 months. 
Methods. Six patients treated via cross-facial nerve grafting between healthy and 
paralyzed middle and middle-upper facial nerve branches and masseteric cooptation of 
the main trunk of the paralyzed facial nerve between 20-24 months after the onset of 
palsy were analyzed. Population consisted of two males and four females ages 8–42 
years (mean 24 years). Facial palsy developed after acoustic neuroma resection in three 
patients, after the removal of a cerebellopontine angle astrocytoma in one, and as a 
consequence of Bell’s palsy or cerebral hemorrhage in the other two (one each). House-
Brackman and Sunnybrook clinical evaluation systems and FDI questionnaire were 
used to assess results. 
Results. House-Brackman scores changed from VI before the operation for all patients 
to II for two patients and III for four patients. Sunnybrook scores were 0–10 before the 
operation but 62–84 at the last visit. Mean FDI scores moved from 24 to 38.5 meaning a 
statistical high significant improvement (p < 0.01). 
Conclusions. Masseteric/cross-facial nerve grafting is feasible for patients with palsies 
20–24 months in duration, affording satisfactory functional and esthetic results and a 
dramatic improvement in quality of life. 
 
Key Words: Facial palsy, Masseteric nerve cooptation, Cross-facial nerve grafting, 
Facial animation, Facial nerve 
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Introduction  
Facial palsy is severely disabling, and the associated functional, psychological, and 
esthetic impairments deeply impact quality of life. Palsies may be classified by the 
involved side (unilateral or bilateral), by severity (complete or incomplete), or by 
etiology (congenital or acquired). However, from a clinical viewpoint, the most 
important factor is the duration of the condition. Palsies are usually divided into recent 
palsies (0–18 months in duration) and established palsies (>18 months in duration or 
congenital palsies)
1
. Duration is critical because treatment options differ greatly by 
time. In those with recent palsies, recovery of the facial mimic muscles is possible, and 
facial nerve cooptation techniques are used to this end. Conversely, in patients with 
congenital or established palsies, muscle recovery may not be possible because of 
muscle atrophy and denervation. Neuromuscular transplants or temporalis muscle 
transfers are usually performed on such patients to reanimate the impaired side of the 
face
2
. 
Although it is widely recognized that palsy duration greatly affects treatment choices, 
the exact cutoff between cooptation and muscle substitution remains unclear. In 
particular, the interval 18–24 months after the onset of palsy is considered a gray area, 
and to the best of our knowledge no reports that focus on this time have yet appeared. 
This interval is thus of great interest to surgeons doing facial palsy reconstruction. The 
surgical choices made have major implications for patients in terms of procedural 
burden, morbidity, expected results, and postoperative recovery and rehabilitation
3,4
. 
Thus, we explored whether facial cooptation, which usually affords good results after a 
rather gentle procedure and which is associated with easy postoperative rehabilitation 
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explored whether the extent of recovery and improvement in quality of life justify the 
use of this approach at such a late time.  
 
Patients and Methods 
Patients treated between January 2009 and May 2016 at the Facial Nerve Center 
(Maxillo-Facial Surgery Division) of the University Hospital of Parma were 
retrospectively reviewed. All included patients had unilateral facial palsy and underwent 
single-stage cross-facial nerve grafting with masseteric nerve cooptation >20 months 
after the onset of palsy. As the work was retrospective in nature, institutional review 
board approval was not required. Our report is written in accordance with the relevant 
guidelines of the Helsinki Declaration. 
Our study population consisted of two males and four females ages 8–42 years (mean 
24 years). Table 1 shows patient’s info. Facial palsy developed after acoustic neuroma 
resection in three patients, after the removal of a cerebellopontine angle astrocytoma in 
one, and as a consequence of Bell’s palsy or cerebral hemorrhage in the other two (one 
each). The time elapsed between the onset of palsy and surgery was 20–24 months 
(mean 22.8 months). 
 
Surgical Technique 
After a pre-auricular incision, dissection began in the subcutaneous plane of the 
healthy side, and facial nerve branches were identified after facial pocket 
harvesting in their terminal part, outside from the parotid gland that was not 
violated. In this dissection, extreme care must be taken to avoid damages to the 
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order to preserve facial muscle activity after their section. Zygomatic-buccal and 
zygomatic-eye branches were selected for cross-facial nerve grafting using neuro-
stimulator and magnification. On the paralyzed side, the facial nerve was dissected 
starting from the main trunk inside the parotid gland. It was dissected completely 
and was followed to identify the zygomatic-buccal and zygomatic-eye branches 
that were used for co-optation with cross-facial nerve grafting. Afterwards, the  
masseteric nerve was identified inside the masseter muscle by using as landmarks 
the zygomatic arch (about 1-2 cm below) and posterior margin of the muscle 
(about 1 cm medially) using neuro-stimulator. Once the masseteric nerve was 
identified, it was dissected and cut in order to increase its mobility. The main trunk 
of the facial nerve was then cut at its origin and rotated to reach the masseter 
nerve and and end-to-end neurorrhaphy was done (Figure 1). Meanwhile, a second 
equipe harvested and split the sural nerve from the leg (usually the right one, but 
patient’s preferences can be taken into account) in order to obtain two long neural 
grafts. These two grafts were passed from the healthy side to the paralyzed one 
through the upper gingivo-buccal sulcus, with the nerve passing in the submucosal 
plane. Finally, neurorrhaphies of the two (middle and middle-upper) cross-facial 
nerve grafting were performed between the grafts and the facial nerve branches 
previously identified (Figure 2, Drawing 1). Pen-rose drainages were placed and 
suturing was performed. 
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the House-Brackman and Sunnybrook facial grading systems) and administration of the 
Facial Disability Index (FDI) quality-of-life questionnaire
5,6
. Children were assisted by 
their parents when completing the questionnaire using methods previously described for 
the evaluation of child patients
7
. All patients underwent cross-facial nerve grafting 
combined with masseteric nerve cooptation in a single-stage operation
8
, according to 
the previously described technique. All patients underwent rehabilitation of the 
periocular complex during the same surgery. This featured platinum eyelid loading and 
inferior palpebral suspension to prevent ocular complications
9,10
. All patients routinely 
received injections of botulinum toxin to improve facial symmetry, with the depressor 
labii and forehead being the most common target areas
11
.  
Retrospective evaluation featured a comparison of the pre- and postoperative scores on 
the FDI questionnaires and those on the House-Brackman and Sunnybrook facial 
grading systems. Results were assessed before administration of botox, but include peri-
ocular rehabilitation that must be performed (as mentioned above) in the same time of 
main procedure in order to provide eye protection and prevent severe complications, 
especially in this subset of patients having a long lasting palsy. Of the 10 items on the 
FDI questionnaire, the first five explore physical function, while the other 5 investigate 
social function and well-being.  We compared scores on the pre- and postoperative FDI 
questionnaires to assess whether quality of life improved. We present pure data (not 
percentages) because this renders the results more comparable. We used the t test in 
SPSS ver. 22.0 (IBM Inc., Armonk, NY, USA) to compare pre- and postoperative data. 
We considered p < 0.05 to reflect statistical significance and p < 0.01 high-level 
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to identify the areas that were most and least affected.  
 
Results 
We recorded no major or minor complications. The clinical results are summarized in 
Table 1. Previously paralyzed muscles began to contract in response to voluntary 
masseteric nerve activation between 4 and 5 months (mean 4.83 months) after the 
operation. Release from biting (the ability to activate contraction without biting) 
developed between 6 and 8 months after the operation (mean 7.17 months), and 
spontaneity (impulses afforded by cross-facial nerve grafting) developed between 9 and 
12 months after the operation (mean 10.17 months). The follow-up duration ranged 
from 12 to 72 months (mean 39 months). Figures 3 and 4 and videos 1 and 2 shows two 
clinical cases comparing pre and post-operative facial muscles contraction. 
Results of FDI questionnarie are summarized in table 2. Preoperative overall scores on 
the six FDI questionnaires ranged from 17 to 37 (mean 24). After the surgery, the scores 
ranged from 33 to 44 (mean 38.5). The difference was highly significant resulting in a  -
14.5 of mean difference with a standard deviation of ± 6.8337 and a mean standard error 
of 2.7899. Ninety-five Confidence interval of the difference ranged between -21.6716 
(lower) and -7.3284 (upper), with a p < 0.01. Statistical analysis is shown in table 3. 
The best improvements in the items investigating physical functions were associated 
with items 1 (“How much difficulty do you have keeping food in your mouth, moving 
food around in your mouth, or getting food stuck in your cheek while eating?”), 3 
(“How much difficulty do you have saying specific sounds while speaking?”), and 4 
(“How much difficulty do you have with your eyes tearing excessively or becoming 
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and 5) also revealed significant improvements (p = 0.11 and 0.17, respectively). 
Amongst those exploring social function and well-being, item 10 (“How often has your 
facial function prevented you from going out to eat, shop, or participate in family or 
social activities?”) improved most: The mean score increased from 2 to 4.17 (p = 
0.015). The least improved score was for item 6 (“How much of the time do you feel 
calm and peaceful?”): The mean score increased from 2.17 to 3.16 (p = 0.041). 
House-Brackman facial grading system scores changed from VI before the operation for 
all patients to III for four patients and II for two; the mean scores thus changed from 6 
to 2.67. Sunnybrook Facial Grading System scores were 0–10 (mean 4.17) before the 
operation but 62–84 (mean 69.7) at the last visit. 
 
Discussion 
The rehabilitation of recent facial palsies has received a great deal of international 
attention and several approaches have been described, particularly over the past 
decade
12
. Facial nerve cooptation procedures are the surgical gold standard, allowing 
recovery of facial mimic muscles before atrophy and denervation render it impossible
13
. 
We are of the view that of the various therapeutic options proposed, combined 
masseteric/cross-facial nerve grafting represents the ideal solution; we published on this 
in detail in 2014. We found that masseteric/cross-facial cooptation ensured rapid, 
reliable, and powerful restoration of muscle activity with extremely low morbidity. 
Contemporaneous cross-facial nerve grafting delivers motor impulses from the 
contralateral healthy facial nerve, affording spontaneity and symmetry of activation and 
yielding very satisfactory results in the great majority of cases.  
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cooptation remains possible; is a neuromuscular transplant the better option? This cutoff 
is generally considered 18 months, but we here report for the first time very satisfactory 
results obtained 22 months after the onset of palsy. This was possible in our present 
subset of patients because of rapid and powerful reinnervation provided by the 
masseteric nerve and probably thanks to the fact that neurotrophic factors were still 
possible due to intact VII nerve; muscle recovery was possible at even a mean of 22.8 
months after the onset of palsy. Once the main trunk of the facial nerve has been 
coopted and the mimic muscles have been recruited once more by masseteric nerve 
activation, the time needed for activation after cross-facial nerve grafting is no longer an 
issue. Initial activation is reflected by voluntary biting (at 4–5 months in our present 
series, mean 4.83 months), and successful postoperative rehabilitation release activation 
from biting (usually after 2 months of treatment). Finally, when the cross-facial graft 
delivers impulses from the contralateral side (at 9–12 months in our current series, mean 
10.17 months), activation becomes both spontaneous and synchronous and tone at rest 
is improved. 
Our major concern is the quality of the results. The literature shows that the quality of 
recovery is strictly (negatively) correlated with the time that has elapsed since 
denervation of the mimic muscle; the best results are obtained in cases treated early
14-16
. 
However, the esthetic and functional outcomes of our patients were satisfactory, as 
demonstrated by their scores on the Sunnybrook Facial Grading System. This system 
was recently identified by the Sir Charles Bell Society as being the most reliable of the 
several alternatives
17
. Although better results could certainly have been achieved had 
the patients been treated earlier, the quality-of-life improvements were dramatic; the 
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analyzed. Note that the best improvements were in areas related to social interaction and 
daily functions such as speaking and eating. The patients were very satisfied. This was, 
of course, our primary goal.  
It is very important to note that rehabilitation involved only a light procedure or 
superficial surgery. The mean operative time was about 3 h. We encountered no 
complications and no morbidity. All patients were discharged after 3 days in hospital. In 
addition, if facial nerve cooptation fails, the cross-facial nerve graft can be used to 
reinnervate the gracilis muscle in a two-step procedure (cross-grafting followed by a 
gracilis neuromuscular transplant reinnervated via the cross-graft)
18,19
. This is normally 
considered the gold-standard treatment for established or congenital unilateral palsy
20
. 
This option should be clearly explained to the patient: It is possible that cooptation may 
fail but the rehabilitation course will not be affected. If, however, cooptation is not 
possible, muscular substitution is indicated. 
Another interesting finding is the absence of any correlation between age and outcome: 
The results in pediatric and adult patients were similar. Our small sample size limits the 
weight of this conclusion, but we have no evidence that cooptation is unreliable in 
elderly patients. 
Certain ancillary procedures are essential for successful rehabilitation. As we 
reported above, all patients underwent upper eyelid loading with platinum chain 
and botulinum toxin injections. Despite the evaluation of results that was assessed 
before botox administration, it is probable that  palpebral rehabilitation with this 
ancillary procedure has partially biased our evaluation of results in this area: 
assessment of results without including upper eyelid evaluation is not possible 
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their scientific validation. Therefore, we choose to include in our assessment this 
area, also with the intent to underline that all patients should receive both 
treatments, even if it is not possible to split “pure” assessment of the benefit of the 
main procedure from the one related to platinum chain loading. On the other hand, 
eyelid loading is essential because when palsies of such long duration are to be 
treated, lagophtalmos and eye discomfort become urgent issues and eyelid loading 
with platinum chain affords rapid and reliable results. Despite satisfactory recovery 
of facial mimicing, no patient required eyelid removal. Thus, after facial recovery, 
loading did not become an issue, as evidenced by the excellent improvement on item 4. 
Botulinum toxin is commonly used as an aid to rehabilitate unilateral palsy, as in our 
patients. The depressor labii and frontalis regions usually exhibit the poorest recoveries, 
particularly when the palsy is of long duration, and none of our patients achieved 
perfect movement in these areas as measured using the Sunnybrook Facial Grading 
System. Thus, chemodenervation of the contralateral side optimally restores facial 
symmetry and is routine in such patients.  
The principal limitations of our study are the small sample size and the retrospective 
nature of the work. However, facial nerve cooptation procedures are not routine, and we 
would have had even fewer patients had we restricted our analysis to patients treated 
20–24 months after the onset of palsy. Future prospective multicenter studies would 
certainly strengthen our findings. Meanwhile, we approached a neglected subset of 
patients for whom surgical decision making is difficult and helped them. 
 
Conclusions 
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to treat palsies 20–24 months in duration, affording satisfactory functional and esthetic 
outcomes and dramatically improving quality of life using a relatively light procedure. 
The English in this document has been checked by at least two professional editors, 
both native speakers of English. For a certificate, please see: 
 
http://www.textcheck.com/certificate/kWexQK 
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Table 1. Patients data and clinical evaluation. Abbreviations: HBFGS, House-
Brackmann Facial Grading; SFGS, Sunnybrook Facial Grading System; CPAA, 
cerebellopontine angle astrocytoma; CH, Cerebral Hemorrhage; AN, Acoustic 
Neuroma. 
Table 2. Results of FDI questionnaire. Table shows scores for each patient and overall 
results.  
Table 3. Statistical evaluation of the FDI questionnaire results. Abbreviations: df, 
degrees of freedom; Std, standard. “Item”: refers to items on the Facial Disability Index 
(FDI) questionnaire. “Mean” refers to the mean difference between the pre and post 
operative scores in the item. 
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Figure 1. Intra-operative picture showing masseteric-facial cooptation. 
Figure 2. Intra-operative picture showing cooptation of middle and upper branches of 
facial nerve with sural nerve used for cross-facial nerve grafting. Masseteric-facial 
cooptation was still visible in the deeper plane. 
Figure 3. Results of the procedure comparing pre-operative (a) and post-operative (b) 
picture of a 42 yo patient treated 24 months after right Bell’s palsy. 
Figure 4. Results of the procedure comparing pre-operative (a) and post-operative (b) 
picture of a 22 yo patient treated 24 months after right palsy resulted from an acoustic 
neuroma resection. 
Drawing 1. Scheme of the procedure. S1: sural nerve graft 1; S2: sural nerve graft 2; 
M: masseteric nerve; T: main trunk of the facial nerve. Proximal stump of masseteric 
nerve (M, black bold line) was rotated and cooptation of distal stump of main trunk of 
facial nerve (T) was performed to provide a full masseteric-facial cooptation.  
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Table 1. Patients data and clinical evaluation. 
 
Abbreviations: HBFGS, House-Brackmann Facial Grading; SFGS, Sunnybrook Facial Grading System; CPAA, cerebellopontine angle astrocytoma;  
                           CH, Cerebral Hemorrhage; AN, Acoustic Neuroma. 
  
 
Patient Sex 
Age 
(Years) 
Side Etiology 
Time from palsy 
to intervention 
(Months) 
Contraction 
(Months from 
surgery to first 
contraction) 
Release 
from biting 
(Months 
required) 
Spontaneity 
(Months 
elapsed to 
achieve 
spontanous 
movements) 
HBFGS 
pre 
HBFGS 
post 
SFGS 
pre 
SFGS 
post 
1 F 42 R Bell’s Palsy 24 5 7 11 6 2 0 62 
2 M 8 L CPAA 24 5 6 9 6 3 10 70 
3 F 22 R AN 24 4 7 11 6 2 5 72 
4 F 40 L AN 20 5 8 12 6 3 0 63 
5 M 16 L CH 21 5 8 9 6 3 5 84 
6 F 16 L AN 24 5 7 9 6 3 5 67 
Mean  - 24  -   - 22.8 4.83 7.17 10.17 6 2.67 4.17 69.7 
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Table 3. FDI Items and scores 
 
  
 
Item 1 
Eating 
Function 
Item 2 
Drinking 
Function 
Item 3 
Speaking 
Function 
Item 4 
Eye 
Comfort 
Item 5 
Brushing 
Teeth 
ability 
Item 6 
Feeling 
Calm and 
Peaceful 
Item 7 
Feeling 
Isolate 
Item 8 
Getting 
Irritable 
Item 9 
Sleep 
Comfort 
Item 10 
Social 
Interaction 
Scores 
Patients pre post pre post pre post pre post pre post pre post pre post pre post pre post pre post pre post 
1 2 4 2 5 2 5 2 4 2 5 1 3 1 4 2 4 2 4 1 5 17 43 
2 2 4 2 4 2 3 2 3 2 4 2 3 2 3 2 3 2 3 2 3 20 33 
3 3 4 3 5 2 3 2 4 3 5 1 3 3 3 0 3 2 4 1 4 20 38 
4 2 3 4 5 3 4 3 4 4 5 2 3 2 4 1 2 4 4 5 5 30 39 
5 5 5 5 5 3 4 3 5 5 5 5 5 4 5 5 5 0 0 2 5 37 44 
6 2 4 2 4 3 4 4 4 3 4 2 2 1 3 1 3 1 3 1 3 20 34 
Mean 2,67 4 3 4,67 2,5 3,83 2,67 4 3,17 4,67 2,17 3,16 2,17 3,67 1,83 3,33 1,83 3 2 4,17 24 38,5 
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Abbreviations: df, degrees of freedom; Std, standard. 
“Item”: refers to items on the Facial Disability Index (FDI) questionnaire. 
“Mean” refers to the mean difference between the pre and post operative scores in the item.  
 
 
 
Items of FDI questionnaire 
(#pre - #post) 
Paired differences    
Mean and  
Std. deviation 
Std error 
mean 
95% Confidence interval of the 
difference 
t-test df P value Lower Upper 
Item 1 #1.1-#2.1 -1.3333 ± 0.8165 0.3333 -2.1902 -0.4765 -4.000 5 <0.01 
Item 2 
#1.2-#2.2 
-1.6667 ± 1.0328 0.4216 -2.7505 -0.5828 -3.953 5 0.011 
Item 3 
#1.3-#2.3 
-1.3333 ± 0.8165 0.3333 -2.1902 -0.4765 -4.000 5 <0.01 
Item 4 
#1.4-#2.4 
-1.3333 ± 0.8165 0.3333 -2.1902 -0.4765 -4.000 5 <0.01 
Item 5 
#1.5-#2.5 
-1.5000 ± 1.0488 0.4282 -2.6007 -0.3993 -3.503 5 0.017 
Item 6 
#1.6-#2.6 
-1.0000 ± 0.8944 0.3651 -1.9386 -0.0614 -2.739 5 0.041 
Item 7 
#1.7-#2.7 
-1.5000 ± 1.0488 0.4282 -2.6007 -0.3993 -3.503 5 0.017 
Item 8 
#1.8-#2.8 
-1.5000 ± 1.0488 0.4282 -2.6007 -0.3993 -3.503 5 0.017 
Item 9 
#1.9-#2.9 
-1.1667 ± 0.9832 0.4014 -2.1985 -0.1349 -2.907 5 0.034 
Item 10 
#1.10-#2.10 
-2.1667 ± 1.4720 0.6009 -3.7114 -0.6219 -3.606 5 0.015 
Score tot 
TOT 1-TOT 2 
-14.5000 ± 6.8337 2.7899 -21.6716 -7.3284 -5.197 5 <0.01 
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